Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP603247.RA1L2yzHvcSsIv0MSz7vHCEpAwDpS6ZtWp-916WPp5cy4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP603247.RA1L2yzHvcSsIv0MSz7vHCEpAwDpS6ZtWp-916WPp5cy4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP603247.RA1L2yzHvcSsIv0MSz7vHCEpAwDpS6ZtWp-916WPp5cy4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP603247.RA1L2yzHvcSsIv0MSz7vHCEpAwDpS6ZtWp-916WPp5cy4130_provenance.
- NP603247.RA1L2yzHvcSsIv0MSz7vHCEpAwDpS6ZtWp-916WPp5cy4130_assertion description "[LY293111 also induces S-phase arrest with downregulation of CDK2, cyclin A and cyclin E. Blockade of leukotriene B4 metabolic pathway may provide a novel treatment for human pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP603247.RA1L2yzHvcSsIv0MSz7vHCEpAwDpS6ZtWp-916WPp5cy4130_provenance.
- NP603247.RA1L2yzHvcSsIv0MSz7vHCEpAwDpS6ZtWp-916WPp5cy4130_assertion evidence source_evidence_literature NP603247.RA1L2yzHvcSsIv0MSz7vHCEpAwDpS6ZtWp-916WPp5cy4130_provenance.
- NP603247.RA1L2yzHvcSsIv0MSz7vHCEpAwDpS6ZtWp-916WPp5cy4130_assertion SIO_000772 17414622 NP603247.RA1L2yzHvcSsIv0MSz7vHCEpAwDpS6ZtWp-916WPp5cy4130_provenance.
- NP603247.RA1L2yzHvcSsIv0MSz7vHCEpAwDpS6ZtWp-916WPp5cy4130_assertion wasDerivedFrom befree-2016 NP603247.RA1L2yzHvcSsIv0MSz7vHCEpAwDpS6ZtWp-916WPp5cy4130_provenance.
- NP603247.RA1L2yzHvcSsIv0MSz7vHCEpAwDpS6ZtWp-916WPp5cy4130_assertion wasGeneratedBy ECO_0000203 NP603247.RA1L2yzHvcSsIv0MSz7vHCEpAwDpS6ZtWp-916WPp5cy4130_provenance.
- befree-2016 importedOn "2016-02-19" NP603247.RA1L2yzHvcSsIv0MSz7vHCEpAwDpS6ZtWp-916WPp5cy4130_provenance.